智通财经APP讯,医思健康(02138)公布截至2025年9月30日止6个月的中期业绩,总收入约19.31亿港元,同比减少6.4%;公司权益股东应占亏损1031.2万港元,同比盈转亏;每股亏损0.9港仙。
公告称,盈利能力下跌主要是归因于收入及销量减少,导致各主要业务部门的经营杠杆降低。服务组合向低利润类别转移,以及去年同期并无贡献盈利的已出售医疗资产收入,进一步拖累集团的盈利。
智通财经APP讯,医思健康(02138)公布截至2025年9月30日止6个月的中期业绩,总收入约19.31亿港元,同比减少6.4%;公司权益股东应占亏损1031.2万港元,同比盈转亏;每股亏损0.9港仙。
公告称,盈利能力下跌主要是归因于收入及销量减少,导致各主要业务部门的经营杠杆降低。服务组合向低利润类别转移,以及去年同期并无贡献盈利的已出售医疗资产收入,进一步拖累集团的盈利。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.